Use of SGLT2 inhibitors in type 2 diabetes: weighing the risks and benefits
Lupsa BC, Inzucchi SE
Diabetologia 2018;61(10):2118-25
Leggi
Lupsa BC, Inzucchi SE
Diabetologia 2018;61(10):2118-25
Leggi
van der Velde JHPM, Schaper NC, Stehouwer CDA, et al.
Diabetologia. Pub. online 10 September 2018
Leggi
Persson M, Shah PS, Rusconi F, et al.
JAMA Pediatr. 2018;172(9):867-75
Leggi
Ohkuma T, Peters SEA, Woodward M
Diabetologia 2018;61(10):2140-54
Leggi
Garg SK, Peters AL, Buse JB, Danne T
Diabetes Technology & Therapeutics. Pub. online 1 Sep 2018
Leggi
Roglic G, Norris SL
Annals of Internal Medicine. 2018;169(5):1-4
Leggi
Park C, Le QA
Diabetes Technology & Therapeutics. Pub. online 1 Sep 2018
Leggi
Gopalan A, Mishra P, Alexeeff SE, et al.
Diabetic Medicine. Pub. online 03 September 2018
Leggi
Ramos R, Comas-Cufí M, Martí-Lluch R, et al.
BMJ 2018;362:k3359
Leggi
Bakris GL, Polonsky TS
Journal of the American College of Cardiology. 2018;72(11):1224
Leggi